FDA Inspection 1067059 — Asclemed USA Inc.

Asclemed USA Inc. — FEI 3001452204

The FDA completed an inspection of Asclemed USA Inc. on Sep 27, 2018 in Torrance, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Sep 27, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrance, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.